GSK cuts losses on $700M upfront Alzheimer’s collab with Alector following 2 clinical failures Read more →

FDA halts release of new drug rejection letters while working to formalize policy Read more →

Prime wins patent fight with Beam to continue work on AATD gene editing therapy Read more →